Singh D, Jain S, Jain A, Jain S
World J Nucl Med. 2024; 23(2):88-94.
PMID: 38933062
PMC: 11199035.
DOI: 10.1055/s-0044-1779748.
Goluch M, Pytlewska A, Sarnecki J, Chodnicka P, Sliwinska A, Obrycki L
BMC Pediatr. 2024; 24(1):213.
PMID: 38528521
PMC: 10962167.
DOI: 10.1186/s12887-024-04694-2.
MacPherson D, Fung K, Cook B, Francesconi L, Zeglis B
Dalton Trans. 2019; 48(39):14547-14565.
PMID: 31556418
PMC: 6829947.
DOI: 10.1039/c9dt03039e.
Aka S, Moulika J, Mohan V, Priya R, Manthri R, Kalawat T
Indian J Nucl Med. 2019; 34(1):57-59.
PMID: 30713384
PMC: 6352639.
DOI: 10.4103/ijnm.IJNM_100_18.
Majd M, Bar-Sever Z, Santos A, De Palma D
J Nucl Med. 2018; 59(10):1636-1640.
PMID: 30275286
PMC: 6167528.
DOI: 10.2967/jnumed.118.215921.
Influence of bladder fullness on the detection of urinary tract obstruction by dynamic renal scintigraphy.
Cosenza N, Lau F, Lima M, Amorim B, Mosci C, Lima M
Radiol Bras. 2017; 50(4):237-243.
PMID: 28894331
PMC: 5586514.
DOI: 10.1590/0100-3984.2016-0061.
Preparation and Evaluation of (68)Ga-ECC as a PET Renal Imaging Agent.
Mirzaei A, Jalilian A, Aghanejad A, Mazidi M, Yousefnia H, Shabani G
Nucl Med Mol Imaging. 2015; 49(3):208-16.
PMID: 26279694
PMC: 4532689.
DOI: 10.1007/s13139-015-0323-7.
Vicarious liver visualization in solitary functioning kidney with technetium-99m ethylenedicysteine renal scintigraphy.
Jain T, Phulsunga R, Gupta N, Sood A, Bhattacharya A, Mittal B
Indian J Nucl Med. 2015; 30(3):272-4.
PMID: 26170576
PMC: 4479922.
DOI: 10.4103/0972-3919.158545.
Comparison of the Relative Renal Function Calculated with 99mTc-Diethylenetriaminepentaacetic Acid and 99mTc-Dimercaptosuccinic Acid in Children.
Celik T, Yalcin H, Gunay E, Ozen A, Ozer C
World J Nucl Med. 2014; 13(3):149-53.
PMID: 25538484
PMC: 4262871.
DOI: 10.4103/1450-1147.144812.
Initial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers.
Lipowska M, Klenc J, Folks R, Taylor A
Nucl Med Mol Imaging. 2014; 48(3):216-24.
PMID: 25177379
PMC: 4145101.
DOI: 10.1007/s13139-014-0270-8.
Measurement of kidney perfusion in critically ill patients.
Schneider A, Goodwin M, Bellomo R
Crit Care. 2013; 17(2):220.
PMID: 23514525
PMC: 3672528.
DOI: 10.1186/cc12529.
Can Tc 99m DTPA be Used in Adult Patients in Evaluation of Relative Renal Function Measurement as the Reference Tc 99m DMSA Method?.
Yalcin H, Ozen A, Gunay E, Ozaslan I, Ozer C
Mol Imaging Radionucl Ther. 2013; 20(1):14-8.
PMID: 23486843
PMC: 3590936.
DOI: 10.4274/MIRT.20.03.
Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.
Papini G, Alidori S, Lewis J, Reichert D, Pellei M, Lobbia G
Dalton Trans. 2008; (1):177-84.
PMID: 19081987
PMC: 4418490.
DOI: 10.1039/b808831d.
Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases.
Ogawa K, Mukai T, Kawai K, Takamura N, Hanaoka H, Hashimoto K
Eur J Nucl Med Mol Imaging. 2008; 36(1):115-21.
PMID: 18709369
DOI: 10.1007/s00259-008-0925-8.
Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors.
Kurihara H, Yang D, Cristofanilli M, Erwin W, Yu D, Kohanim S
Appl Radiat Isot. 2008; 66(9):1175-82.
PMID: 18308577
PMC: 2562036.
DOI: 10.1016/j.apradiso.2008.01.012.
First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M, He H, Malveaux E, Xu X, Marzilli L, Taylor A
J Nucl Med. 2006; 47(6):1032-40.
PMID: 16741314
PMC: 4075153.
Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.
Yang D, Ilgan S, Higuchi T, Zareneyrizi F, Oh C, Liu C
Pharm Res. 1999; 16(5):743-50.
PMID: 10350019
DOI: 10.1023/a:1018836911013.
Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow.
Stoffel M, Jamar F, Van Nerom C, Verbruggen A, Besse T, Squifflet J
Eur J Nucl Med. 1996; 23(4):365-70.
PMID: 8612654
DOI: 10.1007/BF01247362.
Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties.
Vanbilloen H, De Roo M, Verbruggen A
Eur J Nucl Med. 1996; 23(1):40-8.
PMID: 8586100
DOI: 10.1007/BF01736988.
Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells.
Verbeke K, Vanbilloen H, De Roo M, Verbruggen A
Eur J Nucl Med. 1993; 20(6):473-82.
PMID: 8339730
DOI: 10.1007/BF00175159.